Svetlana Mykolayivna Gramatiuk

Dr. Svetlana Mykolayivna Gramatiuk

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
LCLourdes Cruz-Garcia
Lourdes Cruz-Garcia
FNFarah Nasser
Farah Nasser
GOGrainne O’brien
Grainne O’brien
JGJakub Grepl
Jakub Grepl
VVVolodymyr Vinnikov
Volodymyr Vinnikov
Christophe BadieChristophe Badie
Christophe Badie
External beam radiation therapy leads to cellular activation of the DNA damage response (DDR). DNA double-strand breaks (DSBs) activate the ATM/CHEK2/p53 pathway, inducing the transcription of stress genes. The dynamic nature of this transcriptional response has not been directly observed in vivo in humans. In this study we monitored the messenger RNA transcript abundances of nine DNA damage-responsive genes (CDKN1A, GADD45, CCNG1, FDXR, DDB2, MDM2, PHPT1, SESN1, and PUMA), eight of them regulated by p53 in circulating blood leukocytes at different time points (2, 6–8, 16–18, and 24 h) in cancer patients (lung, neck, brain, and pelvis) undergoing radiotherapy. We discovered that, although the calculated mean physical dose to the blood was very low (0.038–0.169 Gy), an upregulation of Ferredoxin reductase (FDXR) gene transcription was detectable 2 h after exposure and was dose dependent from the lowest irradiated percentage of the body (3.5% whole brain) to the highest, (up to 19.4%, pelvic zone) reaching a peak at 6–8 h. The radiation response of the other genes was not strong enough after such low doses to provide meaningful information. Following multiple fractions, the expression level increased further and was still significantly up-regulated by the end of the treatment. Moreover, we compared FDXR transcriptional responses to ionizing radiation (IR) in vivo with healthy donors’ blood cells exposed ex vivo and found a good correlation in the kinetics of expression from the 8-hours time-point onward, suggesting that a molecular transcriptional regulation mechanism yet to be identified is involved. To conclude, we provided the first in vivo human report of IR-induced gene transcription temporal response of a panel of p53-dependant genes. FDXR was demonstrated to be the most responsive gene, able to reliably inform on the low doses following partial body irradiation of the patients, and providing an expression pattern corresponding to the % of body exposed. An extended study would provide individual biological dosimetry information and may reveal inter-individual variability to predict radiotherapy-associated adverse health outcomes.

12 August 2025 in Biopreservation and Biobanking
Verified
Journal Article
Closed access
SGSvetlana Mykolayivna Gramatiuk
Svetlana Mykolayivna Gramatiuk
IKIgor A. Kryvoruchko
Igor A. Kryvoruchko
YIYulia V. Ivanova
Yulia V. Ivanova
EHEmily Hubbard
Emily Hubbard
MNMaria Noebauer-Babenko
Maria Noebauer-Babenko
KSKarine Sargsyan
Karine Sargsyan
Introduction: This study is part of the broader Stem Line project Mito-Cell-UAB073, specifically focusing on “Stem Cell Lines-Quality Control,” and aims to innovate in the field of Quality Control (QC) through a unique, artificial intelligence (AI)-powered model known as Life Cell AI UAB. This model utilizes deep learning algorithms and computer vision, allowing it to make accurate viability assessments of cell and stem cell lines based solely on static images captured through standard optical microscopes. Aim: The aim of this study was to develop and validate an AI-driven, image-based model that reliably predicts cell line viability. Methods: Our methodology involved training the Life Cell AI UAB model on single static images of cell lines using advanced computer vision and deep learning techniques. Performance evaluation was conducted on three independent blind test sets sourced from various biotechnology laboratories, allowing for assessment across diverse environments. Results: The Life Cell AI UAB model achieved a sensitivity of 82.1% in identifying viable cell lines and a specificity of 67.5% for non-viable lines across the test sets. Each blind test set exhibited a weighted accuracy above 63%, with a combined accuracy of 64.3%. Notably, predictions showed a clear distinction between correctly and incorrectly classified cells. The model outperformed traditional QC methods by improving accuracy in binary classification tasks by 21.9% ( p = 0.042) and demonstrated a 42.0% enhancement over conventional Standard Operation Procedure (SOP) procedures ( p = 0.026). Conclusion: The Life Cell AI UAB model represents a notable advancement in biobanking QC, offering a precise, standardized, and non-invasive method for assessing cell line viability. This model has the potential to streamline QC processes across laboratories, minimizing the need for time-lapse imaging and promoting uniformity in QC practices for both cell and stem cells.

1 July 2023 in Journal of Medicine and Life
Verified
Journal Article
Open access
SGSvetlana Mykolayivna Gramatiuk
Svetlana Mykolayivna Gramatiuk
MTMykhailo Tymchenko
Mykhailo Tymchenko
YIYulia Ivanova
Yulia Ivanova
IKIgor Kryvoruchko
Igor Kryvoruchko
KGKyrylo Goltsev
Kyrylo Goltsev
KSKarine Sargsyan
Karine Sargsyan
This study aimed to investigate the effectiveness of combined negative pressure wound therapy (NPWT) and human amniotic membrane in patients with chronic

27 April 2023 in Journal of Fluorescence
Verified
Journal Article
Open access
PDF file
YVYuriy O. Vinnyk
Yuriy O. Vinnyk
IKIgor A. Kryvoruchko
Igor A. Kryvoruchko
VBValeriy Boyko
Valeriy Boyko
YIYulia Ivanova
Yulia Ivanova
SGSvetlana Mykolayivna Gramatiuk
Svetlana Mykolayivna Gramatiuk
KSKarine Sargsyan
Karine Sargsyan
: Phosphorescence is considered one of the non-invasive glioblastoma testing methods based on studying molecular energy and the metabolism of L-tryptophan (Trp) through KP, which provides essential information on regulating immunity and neuronal function. This study aimed to conduct a feasibility study using phosphorescence in clinical oncology as an early prognostic test in detecting Glioblastoma. This study was conducted on 1039 patients who were operated on with follow-up between January 1, 2014, and December 1, 2022, and retrospectively evaluated in participating institutions in Ukraine (the Department of Oncology, Radiation Therapy, Oncosurgery, and Palliative Care at the Kharkiv National Medical University). Method of protein phosphorescence detection included two steps. During the first step, of luminol-dependent phosphorescence intensity in serum was carried out after its activation by the light source, according to the spectrofluorimeter method, as follows. At a temperature of 30 °C, serum drops were dried for 20 min to form a solid film. After that, we put the quartz plate with dried serum in a phosphoroscope of luminescent complex and measured the intensity. With the help of Max-Flux Diffraction Optic Parallel Beam Graded Multilayer Monochromator (Rigaku Americas Corporation) following spectral lines as 297, 313, 334, 365, 404, and 434 nm were distinguished and absorbed by serum film in the form of light quantum. The monochromator exit split width was 0.5 mm. Considering the limitations of each of the non-invasive tools currently available, phosphorescence-based diagnostic methods are ideally integrated into the NIGT platform: a non-invasive approach for visualizing a tumor and its main tumor characteristics in the spatial and temporal order. Because trp is present in virtually every cell in the body, these fluorescent and phosphorescent fingerprints can be used to detect cancer in many different organs. Using phosphorescence, it is possible to create predictive models for GBM in both primary and secondary diagnostics. This will assist clinicians in selecting the appropriate treatment option, monitoring treatment, and adapting to the era of patient-centered precision medicine.

18 July 2024 in Clinical and Preventive Medicine
Verified
Journal Article
Open access
PDF file
JIJuliia V. Ivanova
Juliia V. Ivanova
SGSvetlana Mykolayivna Gramatiuk
Svetlana Mykolayivna Gramatiuk
IKIgor A. Kryvoruchko
Igor A. Kryvoruchko
VPVitaliy O. Prasol
Vitaliy O. Prasol
IPInna S. Pulyaeva
Inna S. Pulyaeva
ІПІнна С. Пуляєва
Інна С. Пуляєва
Aim. To experimentally study the effect of light of different ranges on the proliferation and migration of mesenchymal stem cells of human MSCs and to select its optimal parameters for treatment. Materials and methods. The experiment was conducted in vitro on 260 cultures of human MSCs isolated from peripheral blood by magnetic separation. Cells were treated with pulsed LED light: 475 nm, 516 nm, 635 nm or left unstimulated. All LED devices had a peak radiation intensity of 80 mW/cm2. The average radiation intensity reached 40 mW/cm2. Irradiation was carried out at room temperature for 10 minutes at a distance of 2 cm from the cells. Cells embedded in a 2D fibrin gel matrix to study cell proliferation and a 3D fibrin gel matrix to study cell migration were studied. Hereby, cells used for 2D experiments were stimulated on day 0, while cells embedded in 3D arrays were stimulated on day 0 and then every 24 h until quantification. The effect of different wavelengths on both proliferation and cellular metabolic activity of MSCs from peripheral blood was evaluated after initial light treatment at 24 hours, 48 hours and 72 hours. Results. During the first 48 hours after stimulation, cells proliferated in all studied groups (stimulated and non-stimulated). At the same time, there were no significant differences between the groups at 24 hours and 48 hours. For 2D experiments, cells were stimulated only on day 0, whereas for 3D experiments, stimulation was performed every 24 h. Quantification of cells migrating into the surrounding fibrin gel matrix showed that red and green light stimulation significantly affected 3D migration after 4 days. Irradiation with blue light had no significant effect on migration. Conclusions. Thus, exposure of MSCs to red and green light increases cell proliferation in 2D and 3D environments, while exposure to blue light decreases their metabolic activity. In our opinion, this fact should be used to modernize laboratory equipment and improve treatment regimens for patients using MSCs. Further research on the influence of light on the differentiation of MSCs is promising.

1 January 2021 in Journal of Medicine and Life
Verified
Journal Article
Open access
SGSvetlana Mykolayivna Gramatiuk
Svetlana Mykolayivna Gramatiuk
IBIrina Yuriivna Bagmut
Irina Yuriivna Bagmut
MSMikhail Sheremet
Mikhail Sheremet
KSKarine Sargsyan
Karine Sargsyan
AYAlla Mironovna Yushko
Alla Mironovna Yushko
APAndriy Ivanovich Popovich
Andriy Ivanovich Popovich
Pediatric biobanks are an indispensable resource for the research needed to bring advances in personalized medicine into pediatric medical care. It is unclear how or when these advances in medical care may reach children, but it is unlikely that research in adults will be adequate. We conducted the screening for a hypothetic problem in various European and American pediatric biobanks based on online surveys through e-mail distribution based on the Biobank Economic Modeling Tool (BEMT) questionnaire model. Participants in the survey had work experience in biobanking for at least 3 years or more. Contact information about the survey participants was confirmed on the social networks profiles (LinkedIn), as well as on generally available websites. First, we tried creating a model which can show the pediatric preclinical and basic clinical phase relationship and demonstrate how pediatric biobanking is linked to this process. Furthermore, we tried to look for new trends, and the final goal is to put the acquired knowledge into practice, so medical experts and patients could gain usable benefit from it. We concluded that leading positions must take into account ethical and legal aspects when considering the decision to include children in the biobank collection. However, communication with parents and children is essential. The biobank characteristics influence the biobank's motives to include children in the consent procedure. Moreover, the motives to include children influence how the children are involved in the consent procedure and the extent to which children are able to make voluntary decisions as part of the consent procedure.